Innovations, technologies and methodologies in driving drug discovery developme across Asia
Hans-Joachim Böhm is Global Head of Chemistry at Roche and Center Manager for the Roche Pharma Research and Early Development Site Basel. Prior to this, Hans-Joachim Böhm was President and Research Site Head of Roche Palo Alto from October 2006 to June 2008. H…more ›
Andreas has been a memmber of the Bayer HealthCare Executive COmmittee as Head of Pharmaceuticals Reserch since February 2007. He has also been in charge of Research in the Animal Health Division since March 2011. Andreas has worked at various research institutes in Ge…more ›
Swaine Chen received his Ph.D. in Developmental Biology and an M.D. from Stanford University in 2004. He became interested in applying computational tools to infectious diseases during his post-doc in the lab of Scott Hultgren, Ph.D. at Washington University. Since 20…more ›
Chih-Liang Chin, Ph.D. is Director and Site Lead Imaging, Translational Medicine Research Centre at Merck & Sharp Dohme, Singapore. In this role, Chih-Liang provides leadership and coordination for the development of translational imaging biomarker in nonhuman prim…more ›
Asia's leading conference in the drug discovery and development space
Drug Discovery World Asia is a strategic and scientific conference for discussing innovations, technologies and methodologies in driving drug discovery development across Asia.
It is an event that integrates academia and industry, providing broad, expert coverage of the whole drug discovery and development arena.
Co-located with BioPharma Asia Convention 2012, this is the event to attend if you're committed to drug discovery and development in Asia.
Sponsors
Come to Drug Discovery World Asia and learn how to:
- Integrate the latest drug discovery technologies to become competitive into your research/li>
- Lower the cost of drug development by fast tracking drug discovery processes
- Find potential partners who can complement current drug discovery efforts in Asia
- Fast track research to commercialization in the region
Who should attend:
- Head of R&D
- Head of Global Research
- Head of Drug Discovery
- Chief Scientific Officer
- Principal Scientist
- Principle Clinical Investigator
- Chief Technology Officer
- Head of Translational Research
- Head of Toxicology
- Head of Stemcell Research
- Head of Modelling & Simulation
- Head of Exploratory Development
- Head of Chemistry
- Head of Cell & Molecular Biology
Who should sponsor:
- Drug discovery equipment provider
- Drug discovery technology solution provider
- Drug safety technology vendor
- Diagnostic technologies
- Stem cell technology provider
- Cheminformatics and computer-aided modeling service prodicer
- Systems and predictive biology solution provider
Past speakers include:
- Agency for Science, Technology & Research (A*STAR), Singapore
- Wuxi Pharma, China
- Institute Pasteur, Korea
- Merck & Co., USA
- Boehringer Ingelheim Pharmaceuticals Inc, USA
- Bayer Schering Pharma AG, Germany
- VIA Pharmaceuticals, USA
- Sovicell GmbH, Germany
- Santaris Pharma, Denmark
- Kadmon Pharmaceuticals, USA
- Waseda Bioscience Research Institute, Singapore
